WS #16350

The market is undergoing a violent repricing driven by a dual shock: escalating Middle East tensions pushing Brent crude to a five-month high above $112, and a sector-wide deleveraging of AI-capex-heavy tech stocks. The SMH index has plunged 5%, dragging the broader Nasdaq lower as investors rotate out of high-multiple growth names. Meta Platforms has emerged as the primary casualty of the tech selloff, dropping over 5% after revealing a staggering $825 billion AI capital expenditure plan that has turned its free cash flow negative. This has triggered a broader reassessment of the 'neocloud' thesis, with institutional voices like Bill Ackman explicitly preferring hyperscalers over leveraged AI infrastructure builders. Simultaneously, the energy complex is experiencing a violent supply-side shock. Houthi attacks and regional hostilities have forced Saudi Aramco to evacuate its headquarters and shift to remote work, while Brent crude spikes to $113. This is not a benign rally; it is a supply disruption that is actively crushing consumer margins and airline profitability. P&G has already raised its 2027 cost outlook to $1.4 billion to offset these energy costs, signaling that inflationary pressures are returning to the consumer sector. The US government has attempted to counter this by tapping heating oil reserves, but the market reaction remains bearish for the broader economy. In a stark divergence from the tech and energy chaos, defensive consumer staples and biotech are seeing idiosyncratic moves. Procter & Gamble hit a 52-week high despite the macro headwinds, likely acting as a safe haven. Conversely, Moderna has crashed 20% on leaked data regarding its cancer vaccine, a specific company-level failure that is isolated from the macro trends. The narrative arc for Middle East tensions is firmly ESCALATING, and the tech narrative is shifting from 'AI optimism' to 'AI margin destruction'.